nsubstitut
isatin
deriv
prepar
reaction
isatin
variou
bromid
via
two
step
bioactiv
assay
result
vitro
test
demonstr
compound
potent
select
inhibitor
sar
coronaviru
proteas
ic
valu
rang
lm
addit
isatin
exhibit
potent
inhibit
sar
coronaviru
proteas
proteas
includ
papain
chymotrypsin
trypsin
sever
acut
respiratori
syndrom
sar
new
viral
atyp
pneumonia
infecti
diseas
origin
southern
china
hong
kong
late
rapidli
spread
countri
common
symptom
sar
cough
high
fever
chill
rigor
myalgia
headach
dizzi
well
progress
radiograph
chang
chest
lymphopenia
diseas
quit
high
mortal
rate
initi
outbreak
death
may
result
progress
respiratori
failur
owe
alveolar
damag
earli
novel
human
coronaviru
identifi
caus
agent
sar
viru
name
sar
coronaviru
sar
cov
date
effect
antivir
drug
vaccin
market
treat
sar
although
steroid
ribavirin
use
empir
hospit
hong
kong
hiv
proteas
inhibitor
nelfinavir
could
decreas
replic
sar
cov
preliminari
vitro
examin
viewpoint
drug
design
human
cov
main
proteas
attract
target
due
import
cleavag
cov
polyprotein
function
polypeptid
previou
studi
report
structur
activ
site
human
cov
main
proteas
cov
proteas
cov
pro
resembl
picornaviru
proteas
one
human
rhinoviru
subtyp
picornaviru
proteas
inhibitor
previous
suggest
good
potenti
lead
compound
develop
sar
cov
pro
inhibitor
howev
fail
inhibit
sar
cov
pro
vitro
laboratori
recent
peptid
deriv
report
activ
inhibitor
sar
cov
pro
sever
type
small
molecul
screen
variou
chemic
librari
identifi
potent
sar
coronaviru
proteas
inhibitor
ic
valu
low
micro
molar
rang
howev
small
molecul
may
unsuit
structur
modif
complex
structur
eg
sabadinin
consequ
innov
scaffold
easi
synthes
chemic
modifi
must
explor
report
preliminari
work
synthesi
evalu
isatin
deriv
effect
sar
cov
pro
inhibitor
investig
laboratori
describ
known
certain
isatin
compound
potent
inhibitor
rhinoviru
proteas
appar
isatin
scaffold
derivat
may
provid
good
candid
sar
cov
pro
inhibitor
proteas
human
sar
cov
rhinoviru
cystein
proteas
structur
similar
activ
site
synthesi
nprotect
isatin
deriv
straightforward
nalkyl
correspond
isatin
sodium
hydrid
variou
bromid
compound
transform
correspond
alcohol
methyl
deriv
dmf
provid
desir
compound
shown
scheme
moder
yield
achiev
depend
substitut
group
isatin
sar
cov
pro
inhibit
assay
conduct
via
fluoresc
reson
energi
transfer
fret
accord
report
protocol
fret
result
confirm
hplc
analysi
fragment
peak
cleav
pro
tabl
list
vitro
bioactiv
compound
sar
cov
proteas
ic
valu
percentag
inhibit
lm
ic
valu
exceed
lm
tabl
measur
via
fret
assay
bioactiv
compound
depend
substitut
group
isatin
scaffold
side
chain
ic
valu
demonstr
potent
substitut
group
isatin
scaffold
benzothiophenemethyl
side
chain
provid
inhibitori
effect
benzyl
heterocycl
substitut
methyl
alkyl
group
although
thiophenecarboxyl
ester
report
potent
inhibitor
ic
lm
sar
proteas
isatin
side
chain
thiophenecarboxyl
amid
exhibit
moder
inhibit
effect
sarscov
proteas
ic
lm
comput
model
fig
show
compound
fit
activ
pocket
sar
cov
pro
moreov
isatin
scaffold
dock
scheme
site
side
chain
r
locat
site
cov
pro
carbonyl
group
isatin
nh
group
proteas
hydrogen
bond
hand
steric
effect
isatin
scaffold
crucial
ensur
inhibitori
potenc
therefor
inhibitor
bulkier
side
chain
less
potent
compound
limit
space
r
isatin
proteas
comput
studi
also
demonstr
inhibitori
potenc
depend
heavili
hydrophob
electron
affin
substitut
group
isatin
exampl
compound
nonpolar
electron
withdraw
group
bromo
nitro
r
significantli
potent
compound
amino
group
r
mixtur
sar
cov
pro
nm
variou
concentr
compound
lm
ph
buffer
contain
trishcl
mm
nacl
mm
edta
mm
dtt
mm
bme
mm
incub
min
room
temperatur
fluorogen
substrat
dabcylktsavlqsgfrkmeedan
lm
ad
fluoresc
chang
result
reaction
measur
continu
monitor
fusionalpha
basic
domest
system
excit
nm
emiss
nm
initi
veloc
inhibit
reaction
plot
differ
inhibitor
concentr
obtain
ic
tabl
show
isatin
exhibit
potent
inhibit
sar
cov
pro
proteas
papain
time
trypsin
time
howev
isatin
inhibit
chymotrypsin
unexpectedli
low
ic
valu
compar
compound
lm
vs
mm
consequ
less
specif
sar
cov
pro
comput
dock
compound
slightli
better
kcal
mol
bind
affin
sar
cov
pro
slight
differ
might
reason
compound
specif
compound
proteas
conclus
seri
nsubstitut
isatin
deriv
simpli
prepar
isatin
sodium
hydrid
variou
bromid
deriv
inhibit
activ
compound
sar
cov
pro
assess
fret
confirm
via
hplc
analysi
ic
valu
demonstr
isatin
deriv
inhibit
sar
cov
pro
low
micro
molar
rang
lm
knowledg
compound
one
potent
select
sar
cov
pro
inhibitor
report
date
